SCOPUS 정보 검색 플랫폼

Volumn 68, Issue 6, 2009, Pages 1072-1073

Tendency towards erosive regression on magnetic resonance imaging at 12 months in rheumatoid arthritis patients treated with rituximab

(7) Døhn, U Møller a,e Ostergaard M a,b,e Bird, P c Boonen, A d Johansen, J S b Moller J M b Hansen, M S b

a Copenhagen University Hospital at Hvidovre ^* (Denmark)

b GENTOFTE UNIVERSITY HOSPITAL (Denmark)

c UNIVERSITY OF NEW SOUTH WALES (Australia)

d MAASTRICHT UNIVERSITY MEDICAL CENTER (Netherlands)

e HVIDOVRE HOSPITAL (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGED; BONE EROSION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DISEASE COURSE; DRUG WITHDRAWAL; EDEMA; FEMALE; FOOT; HAND; HUMAN; IMAGE RECONSTRUCTION; LETTER; METACARPOPHALANGEAL JOINT; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PRIORITY JOURNAL; RADIOGRAPHY; REMISSION; RHEUMATOID ARTHRITIS; SYNOVITIS; WRIST;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; JOINTS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 67449143734 PISSN: 00034967 EISSN: 14682060 Source Type: Journal
DOI: 10.1136/ard.2008.098962 Document Type: Letter

Times cited : (8)

References (4)

1
- 19944430372
- The EULAR-OMERACT rheumatoid arthritis MRI reference image atlas
- Østergaard M, Edmonds J, McQueen F, Peterfy C, Lassere M, Ejbjerg B, et al. The EULAR-OMERACT rheumatoid arthritis MRI reference image atlas. Ann Rheum Dis 2005;64(Suppl 1):i2-i55.
- (2005) Ann Rheum Dis , vol.64 , Issue.SUPPL. 1
- Østergaard, M.¹ Edmonds, J.² McQueen, F.³ Peterfy, C.⁴ Lassere, M.⁵ Ejbjerg, B.⁶

2
- 0033984107
- How to read radiographs according to the Sharp/van der Heijde method
- van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000;27:261-263 (Pubitemid 30058662)
- (2000) Journal of Rheumatology , vol.27 , Issue.1 , pp. 261-263
- Van Der Heijde, D.¹

3
- 33746961890
- Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
- DOI 10.1002/art.22025
- Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, et al. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 2006;54:2793-2806 (Pubitemid 44497758)
- (2006) Arthritis and Rheumatism , vol.54 , Issue.9 , pp. 2793-2806
- Cohen, S.B.¹ Emery, P.² Greenwald, M.W.³ Dougados, M.⁴ Furie, R.A.⁵ Genovese, M.C.⁶ Keystone, E.C.⁷ Loveless, J.E.⁸ Burmester, G.-R.⁹ Cravets, M.W.¹⁰ Hessey, E.W.¹¹ Shaw, T.¹² Totoritis, M.C.¹³

4
- 58849088519
- Rituximab inhibits structural joint damage in rheumatoid arthritis patients with an inadequate response to tumour necrosis factor inhibitor therapies
- Keystone EC, Emery P, Peterfy CG, Tak PP, Cohen S, Genovese MC, et al. Rituximab inhibits structural joint damage in rheumatoid arthritis patients with an inadequate response to tumour necrosis factor inhibitor therapies. Ann Rheum Dis 2009;68:216-221
- (2009) Ann Rheum Dis , vol.68 , pp. 216-221
- Keystone, E.C.¹ Emery, P.² Peterfy, C.G.³ Tak, P.P.⁴ Cohen, S.⁵ Genovese, M.C.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.